BIOND Solutions
Delft
About BIOND Solutions
BI/OND empowers diversity in biological studies by engineering microchips. We are all different in unique ways, yet modern treatments ignore individuals’ genetic variations. People from different ethnicities, gender, ages are limited to take drugs based on a genetic set entirely different from their own. We invented a computer chip where biologists can put your cells. The chip nourishes, stimulates and monitors them as they were in your body. All these functionalities allow finding the medicine specifically meant for you.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $5.1M
- Funding stage: Seed
- Last round: Seed (Mar 2022)
- Website: gobiond.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Semiconductor
Social Profiles
Canonical: https://fsome.com/organization/biond-solutions-72769 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.